http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016526016-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-574 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-282 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 |
| filingDate | 2014-04-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2016-09-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2016526016-A |
| titleOfInvention | How to treat cancer |
| abstract | Methods of treating breast cancer comprising FGFR1 gene amplification, FGFR1 overexpression, FGFR3 overexpression, FGFR3 gene amplification, FGF2 overexpression, and / or FGF2 gene amplification are provided. In some embodiments, the method comprises administering a fibroblast growth factor receptor 1 (FGFR1) extracellular domain (ECD) and / or an FGFR1 ECD fusion molecule. In some embodiments, the method comprises administering FGFR1 ECD and / or FGFR1 ECD fusion molecule in combination with at least one additional therapeutic agent. In some embodiments, a method of treating cancer is provided that comprises administering an FGFR1 ECD and / or FGFR1 ECD fusion molecule in combination with at least one chemotherapeutic agent. |
| priorityDate | 2013-05-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 2326.